[1] Csendes A,Burdiles P,Maluenda F,et al. Simultaneous bacteriologic assessment of bile from gallbladder and common bile duct in control subjects and patients with gallstones and common duct stones. Arch Surg,1996,131（4）: 389-394.
[2] Vitetta L,Best SP,Sali A. Single and multiple cholesterol gallstones and the influence of bacteria. Med Hypotheses,2000,55（6）:502-506.
[3] Maekawa S,Nomura R,Murase T,et al. Endoscopic gallbladder stenting for acute cholecystitis. J UOEH,2014,36（4）:265-272. [4] Eachempati SR,Cocanour CS,Dultz LA,et al. Acute cholecystitis in the sick patient. Curr Prob Surg, 2014,51（11）:441-466.
[5] Wetter LA,Hamadeh RM,Griffiss JM,et al. Differences in outer membrane characteristics between gallstone-associated bacteria and normal bacterial flora. Lancet,1994 19,343（8895）:444-448.
[6] Monstein HJ,Jonsson Y,Zdolsek J, et al. Identification of helicobacter pylori DNA in human cholesterol gallstones. Scand J Gastroenterol,2002,37（1）:112-119.
[7] Fukunaga FH. Gallbladder bacteriology,histology,and gallstones. Study of unselected cholecystectomy specimens in Honolulu. Arch Surg,1973,106（2）:169-171.
[8] Moazeni-Bistgani M,Imani R. Bile bacteria of patients with cholelithiasis and their antibiogram. Acta Med Iran,2013,51（11）:779-783.
[9] Custovic A,Smajlovic J,Tihic N,et al. Epidemiological monitoring of nosocomial infections caused by acinetobacter baumannii. Med Arch,2014,68（6）:402-406.
[10] Sinanan MN. Acute cholangitis. Infect Dis Clin North Am,1992,6:571-599.
[11] Gomes LV,Morey AT,Santos JP,et al. Commensal and environmental vancomycin-resistant enterococcus faecium isolated in hospital settings:genotypic diversity, antimicrobial resistance and virulence traits. Indian J Med Microbiol,2014,32（3）:345-347.
[12] Lee CS,Doi Y. Therapy of infections due to carbapenem- resistant gram-negative pathogens. Infect Chemother,2014,46（3）:149-164.
[13] Temkin E, Adler A,Lerner A,et al. Carbapenem-resistant enterobacteriaceae: biology,epidemiology,and management. Ann N Y Acad Sci,2014,1323:22-42.
[14] Hoffman DW,Whitworth CA,Jones KL,et al. Nutritional status, glutathione levels,and ototoxicity of loop diuretics and aminoglycoside antibiotics. Hear Res,1987,31（3）:217-222.
[15] Tanaka A,Takada T,Kawarada Y,et al. Antimicrobial therapy for acute cholangitis:Tokyo guidelines. J Hepatobiliary Pancreat Surg,2007,14:59-67.
[16] Barber KE,King ST,Stover KR,et al. Therapeutic options for vancomycin-resistant enterococcal bacteremia. Expert Rev Anti Infect Ther,2015,13（3）:363-377.
[17] Mutters NT,Mersch- Sundermann V,Mutters R,et al. Control of the spread of vancomycin-resistant enterococci in hospitals: epidemiology and clinical relevance.Dtsch Arztebl Int,2013, 110（43）:725-731.
[18] Negm AA,Schott A,Vonberg RP,et al. Routine bile collection for microbiological analysis during cholangiography and its impact on the management of cholangitis. Gastrointest Endosc, 2010,72:284-291. |
